Observational studyInternational journal of hematology2024

Long-term safety and effectiveness of romiplostim for chronic idiopathic thrombocytopenic purpura in real-world settings.

Naoshi Obara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.